vs
Bowman Consulting Group Ltd.（BWMN）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
Bowman Consulting Group Ltd.的季度营收约是RIGEL PHARMACEUTICALS INC的1.8倍（$129.0M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 1.5%，领先382.5%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 13.9%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 16.6%）
SLR咨询是一家私有的国际可持续发展咨询企业，在欧洲、北美洲、南美洲、大洋洲及非洲均设有办事处。公司以「推动可持续发展落地」为宗旨，凭借遍布全球的专业顾问与技术团队，携手客户共同应对全球最复杂的各类可持续发展挑战。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
BWMN vs RIGL — 直观对比
营收规模更大
BWMN
是对方的1.8倍
$69.8M
营收增速更快
RIGL
高出7.3%
13.9%
净利率更高
RIGL
高出382.5%
1.5%
两年增速更快
RIGL
近两年复合增速
16.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $129.0M | $69.8M |
| 净利润 | $2.0M | $268.1M |
| 毛利率 | 55.0% | 91.5% |
| 营业利润率 | 3.2% | 33.2% |
| 净利率 | 1.5% | 384.0% |
| 营收同比 | 13.9% | 21.2% |
| 净利润同比 | -66.7% | 1769.2% |
| 每股收益（稀释后） | $0.13 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BWMNRIGL
| Q4 25 | $129.0M | $69.8M | ||
| Q3 25 | $126.0M | $69.5M | ||
| Q2 25 | $122.1M | $101.7M | ||
| Q1 25 | $112.9M | $53.3M | ||
| Q4 24 | $113.2M | $57.6M | ||
| Q3 24 | $113.9M | $55.3M | ||
| Q2 24 | $104.5M | $36.8M | ||
| Q1 24 | $94.9M | $29.5M |
净利润BWMNRIGL
| Q4 25 | $2.0M | $268.1M | ||
| Q3 25 | $6.6M | $27.9M | ||
| Q2 25 | $6.0M | $59.6M | ||
| Q1 25 | $-1.7M | $11.4M | ||
| Q4 24 | $5.9M | $14.3M | ||
| Q3 24 | $771.0K | $12.4M | ||
| Q2 24 | $-2.1M | $-1.0M | ||
| Q1 24 | $-1.6M | $-8.2M |
毛利率BWMNRIGL
| Q4 25 | 55.0% | 91.5% | ||
| Q3 25 | 53.1% | 93.2% | ||
| Q2 25 | 53.7% | 95.6% | ||
| Q1 25 | 51.4% | 91.7% | ||
| Q4 24 | 53.2% | 89.9% | ||
| Q3 24 | 52.4% | 85.5% | ||
| Q2 24 | 52.5% | 92.4% | ||
| Q1 24 | 50.6% | 93.1% |
营业利润率BWMNRIGL
| Q4 25 | 3.2% | 33.2% | ||
| Q3 25 | 4.2% | 40.9% | ||
| Q2 25 | 7.4% | 60.1% | ||
| Q1 25 | 1.0% | 23.9% | ||
| Q4 24 | 1.2% | 28.9% | ||
| Q3 24 | 0.4% | 25.4% | ||
| Q2 24 | -1.2% | 1.2% | ||
| Q1 24 | -2.8% | -23.6% |
净利率BWMNRIGL
| Q4 25 | 1.5% | 384.0% | ||
| Q3 25 | 5.3% | 40.2% | ||
| Q2 25 | 4.9% | 58.6% | ||
| Q1 25 | -1.5% | 21.5% | ||
| Q4 24 | 5.2% | 24.9% | ||
| Q3 24 | 0.7% | 22.5% | ||
| Q2 24 | -2.0% | -2.8% | ||
| Q1 24 | -1.6% | -27.9% |
每股收益（稀释后）BWMNRIGL
| Q4 25 | $0.13 | $14.11 | ||
| Q3 25 | $0.37 | $1.46 | ||
| Q2 25 | $0.34 | $3.28 | ||
| Q1 25 | $-0.11 | $0.63 | ||
| Q4 24 | $0.37 | $0.82 | ||
| Q3 24 | $0.04 | $0.70 | ||
| Q2 24 | $-0.13 | $-0.06 | ||
| Q1 24 | $-0.11 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.1M | $155.0M |
| 总债务越低越好 | $57.6M | $52.5M |
| 股东权益账面价值 | $261.1M | $391.5M |
| 总资产 | $579.7M | $513.6M |
| 负债/权益比越低杠杆越低 | 0.22× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资BWMNRIGL
| Q4 25 | $11.1M | $155.0M | ||
| Q3 25 | $16.2M | $137.1M | ||
| Q2 25 | $15.5M | $108.4M | ||
| Q1 25 | $10.7M | $77.1M | ||
| Q4 24 | $6.7M | $77.3M | ||
| Q3 24 | $11.7M | $61.1M | ||
| Q2 24 | $23.1M | $49.1M | ||
| Q1 24 | $11.7M | $49.5M |
总债务BWMNRIGL
| Q4 25 | $57.6M | $52.5M | ||
| Q3 25 | $29.8M | $60.0M | ||
| Q2 25 | $32.0M | $60.0M | ||
| Q1 25 | $36.4M | $60.0M | ||
| Q4 24 | $38.1M | $60.0M | ||
| Q3 24 | $36.4M | $60.0M | ||
| Q2 24 | $38.8M | $60.0M | ||
| Q1 24 | $26.8M | $60.0M |
股东权益BWMNRIGL
| Q4 25 | $261.1M | $391.5M | ||
| Q3 25 | $261.8M | $117.6M | ||
| Q2 25 | $249.6M | $81.9M | ||
| Q1 25 | $244.1M | $18.6M | ||
| Q4 24 | $246.1M | $3.3M | ||
| Q3 24 | $243.2M | $-14.6M | ||
| Q2 24 | $235.6M | $-29.9M | ||
| Q1 24 | $167.3M | $-31.7M |
总资产BWMNRIGL
| Q4 25 | $579.7M | $513.6M | ||
| Q3 25 | $510.2M | $242.5M | ||
| Q2 25 | $538.2M | $206.7M | ||
| Q1 25 | $528.7M | $176.0M | ||
| Q4 24 | $505.9M | $164.0M | ||
| Q3 24 | $497.0M | $139.4M | ||
| Q2 24 | $463.4M | $128.4M | ||
| Q1 24 | $420.5M | $126.5M |
负债/权益比BWMNRIGL
| Q4 25 | 0.22× | 0.13× | ||
| Q3 25 | 0.11× | 0.51× | ||
| Q2 25 | 0.13× | 0.73× | ||
| Q1 25 | 0.15× | 3.23× | ||
| Q4 24 | 0.15× | 18.25× | ||
| Q3 24 | 0.15× | — | ||
| Q2 24 | 0.16× | — | ||
| Q1 24 | 0.16× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $9.4M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $8.1M | — |
| 自由现金流率自由现金流/营收 | 6.3% | — |
| 资本支出强度资本支出/营收 | 0.9% | — |
| 现金转化率经营现金流/净利润 | 4.76× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $33.4M | — |
8季度趋势，按日历期对齐
经营现金流BWMNRIGL
| Q4 25 | $9.4M | $22.0M | ||
| Q3 25 | $10.2M | $24.0M | ||
| Q2 25 | $4.3M | $30.5M | ||
| Q1 25 | $12.0M | $-893.0K | ||
| Q4 24 | $11.9M | $14.5M | ||
| Q3 24 | $6.8M | $21.7M | ||
| Q2 24 | $3.1M | $302.0K | ||
| Q1 24 | $2.5M | $-5.0M |
自由现金流BWMNRIGL
| Q4 25 | $8.1M | — | ||
| Q3 25 | $10.1M | — | ||
| Q2 25 | $4.2M | — | ||
| Q1 25 | $11.0M | — | ||
| Q4 24 | $11.7M | — | ||
| Q3 24 | $6.6M | — | ||
| Q2 24 | $2.7M | — | ||
| Q1 24 | $2.3M | — |
自由现金流率BWMNRIGL
| Q4 25 | 6.3% | — | ||
| Q3 25 | 8.0% | — | ||
| Q2 25 | 3.4% | — | ||
| Q1 25 | 9.7% | — | ||
| Q4 24 | 10.4% | — | ||
| Q3 24 | 5.8% | — | ||
| Q2 24 | 2.6% | — | ||
| Q1 24 | 2.4% | — |
资本支出强度BWMNRIGL
| Q4 25 | 0.9% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.9% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | 0.3% | — |
现金转化率BWMNRIGL
| Q4 25 | 4.76× | 0.08× | ||
| Q3 25 | 1.54× | 0.86× | ||
| Q2 25 | 0.71× | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | 2.02× | 1.01× | ||
| Q3 24 | 8.81× | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
